SEC Form 4 · accession 0001209191-18-026121
ALDER BIOPHARMACEUTICALS INC · ALDR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric G Carter
Officer — Interim Chief Medical Officer
Period of report
Apr 23, 2018
Accepted (ET)
Apr 25, 2018 · 5:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001423824
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $13.65 | Apr 23, 2018 | A | 75,000 | A | — | Apr 22, 2028 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1If the Reporting person remains continuously employed with the Issuer in good standing through the earlier to occur of (i) the twelve (12)-month anniversary of April 23, 2018 and (ii) the date that a new Chief Medical Officer begins employment with the Issuer (such earlier date, the "End Date"), 100% of the shares subject to the option will immediately vest on the End Date.